Skip to content
Thursday, 5 November 2026

The Ledger Asia

Trusted Insights. Asian Perspective.

Subscribe
Markets

Big Caring’s RM1.40 Valuation: Strong Growth Case, but How Much Depends on the Multiple?

M+Global values Big Caring at RM1.40, above MBSB’s RM1.20 assessment despite a lower headline FY2028 profit forecast. The Ledger Asia examines the valuation assumptions, growth prospects and financial commitments behind the difference.

By Abigail Cheong6 min read

M+Global’s IPO analysis supports the pharmacy group’s expansion prospects. Its higher valuation also highlights the importance of peer selection, supplier income and cash commitments after listing.

KUALA LUMPUR, November 5, 2026: Big Caring Group Bhd’s investment case has gained support from M+Global Research, which assigns the pharmacy operator a fair value of RM1.40 per share, compared with its RM1.08 IPO price.

The November 4 non-rated research note presents evidence of an expanding network, improving purchasing economics and substantial operating cash generation. It also identifies obligations and operating risks that deserve attention alongside the projected returns.

Unlock the Full Article

This article is exclusive to The Ledger Asia Subsribers / PAID members.

Subscribe to Read More

Already have an account? Log in here

This content has been restricted to logged-in users only. Please log in to view this content.

Author

  • Abigail Cheong

    I am Abigail, a journalist at The Ledger Asia, covering business and finance with a focus on the Malaysian Stock Market and key economic developments across Asia. Known for clear, accessible reporting, I deliver insights that help readers understand market trends, corporate movements, and regional news shaping the Asian economy.